drugset / Trial / NCT07662798

A Study of Food Effect on Tersolisib (LY4064809) in Healthy Participants

NCT07662798

Phase 1 Recruiting 60 enrolled Eli Lilly and Company
RandomizedCrossoverOpen-labelBasic science

Summary

The main purpose of this study is to measure how food affects the amount of tersolisib that gets into the bloodstream. Each participant will receive two single oral doses of tersolisib, one under fasted conditions and one with either a high-fat or a low-fat meal. Blood tests will be performed to investigate how the body processes the study drug under each condition. For each participant, the study will last about 9 weeks and will include a stay in the Clinical Research Unit (CRU) lasting almost a month.

Timeline

Start
2026-07-01
Primary completion
2026-09
Completion
2026-09

Drugs

EvaluationDrugModalityDoseRoute
Subject STX-478 Small molecule Oral

Indications

No indication recorded.